What The Study Did:
The implementation of swab screening program for COVID-19 cancer patients prior to each cycle of anticancer therapy at a hospital in the United Arab Emirates was assessed in this study.
Authors:
Humaid O. Al-Shamsi, M.D., of the Burjeel Oncology-Burjeel Medical City in Abu Dhabi, United Arab Emirates, is the corresponding author.
To access the embargoed study:
Visit our For The Media website at this link
https:/
/
media.
jamanetwork.
com/
(doi:10.1001/jamaoncol.2020.5745)
Editor’s Note:
The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
###
Media advisory:
The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article
This link will be live at the embargo time
https:/
/
jamanetwork.
com/
journals/
jamaoncology/
fullarticle/
10.
1001/
jamaoncol.
2020.
5745?guestAccessKey=
4ac8ddf1-0b6c-428f-b26a-8c77ef56e676&utm_source=
For_The_Media&utm_medium=
referral&utm_campaign=
ftm_links&utm_content=
tfl&utm_term=
110520
This part of information is sourced from https://www.eurekalert.org/pub_releases/2020-11/jn-ssf110320.php